VNRX
Price:
$0.6
Market Cap:
$55.26M
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2012-03-02
Stock Exchange
AMEX
Ticker
VNRX
According to VolitionRx Limited’s latest financial reports and current stock price. The company's current ROE is 274.42%. This represents a change of 80.87% compared to the average of 151.72% of the last 4 quarters.
The mean historical ROE of VolitionRx Limited over the last ten years is -150.18%. The current 274.42% ROE has changed -282.73% with respect to the historical average. Over the past ten years (40 quarters), VNRX's ROE was at its highest in in the September 2023 quarter at 409.75%. The ROE was at its lowest in in the December 2014 quarter at -255.84%.
Average
-150.18%
Median
-136.83%
Minimum
-2230.85%
Maximum
1.18%
Discovering the peaks and valleys of VolitionRx Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 309.26%
Maximum Annual ROE = 1.18%
Minimum Annual Increase = -882.10%
Minimum Annual ROE = -2230.85%
Year | ROE | Change |
---|---|---|
2023 | 452.68% | -61.49% |
2022 | 1.18% | -882.10% |
2021 | -150.30% | 19.91% |
2020 | -125.34% | 11.03% |
2019 | -112.89% | -23.90% |
2018 | -148.34% | 0.01% |
2017 | -148.32% | 163.80% |
2016 | -56.22% | -64.34% |
2015 | -157.67% | -92.93% |
2014 | -2230.85% | 309.26% |
The current ROE of VolitionRx Limited (VNRX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
492.62%
5-year avg
247.93%
10-year avg
-150.18%
VolitionRx Limited’s ROE is greater than electroCore, Inc. (-165.17%), greater than Conformis, Inc. (-86.46%), greater than Evogene Ltd. (-189.58%), less than Evolus, Inc. (9.25%), greater than OncoCyte Corporation (-140.65%),
Company | ROE | Market cap |
---|---|---|
-165.17% | $79.43M | |
-86.46% | $17.88M | |
-189.58% | $11.21M | |
9.25% | $1.04B | |
-140.65% | $48.82M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VolitionRx Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like VolitionRx Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is VolitionRx Limited's ROE?
How is the ROE calculated for VolitionRx Limited (VNRX)?
What is the highest ROE for VolitionRx Limited (VNRX)?
What is the 3-year average ROE for VolitionRx Limited (VNRX)?
What is the 5-year average ROE for VolitionRx Limited (VNRX)?
How does the current ROE for VolitionRx Limited (VNRX) compare to its historical average?